These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23197684)

  • 1. Gender differences in clinical presentation and prognosis of uveal melanoma.
    Zloto O; Pe'er J; Frenkel S
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):652-6. PubMed ID: 23197684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal metastasis revealing lung cancer.
    Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative survival of patients with uveal melanoma managed in a single center.
    Caminal JM; Ribes J; Clèries R; Ibáñez N; Arias L; Piulats JM; Pera J; Gutierrez C; Arruga J
    Melanoma Res; 2012 Jun; 22(3):271-7. PubMed ID: 22516965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma in England: trends over time and geographical variation.
    Keenan TD; Yeates D; Goldacre MJ
    Br J Ophthalmol; 2012 Nov; 96(11):1415-9. PubMed ID: 22976582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of uveal melanoma in Sweden from 1960 to 1998.
    Bergman L; Seregard S; Nilsson B; Ringborg U; Lundell G; Ragnarsson-Olding B
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2579-83. PubMed ID: 12147588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Melanoma 92". epidemiological study of uveal melanoma in France].
    Vidal JL; Bacin F; Albuisson E; Rozan R; Desjardins L; D'Hermies F; Grange JD; Chauvel P; Caujolle JP; Sahel J
    J Fr Ophtalmol; 1995; 18(8-9):520-8. PubMed ID: 7560797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease.
    Cerbone L; Van Ginderdeuren R; Van den Oord J; Fieuws S; Spileers W; Van Eenoo L; Wozniak A; Sternberg CN; Schöffski P
    Oncology; 2014; 86(3):185-9. PubMed ID: 24776955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal melanoma among Finnish children and young adults.
    Al-Jamal RT; Kivelä T
    J AAPOS; 2014 Feb; 18(1):61-6. PubMed ID: 24568985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
    Kujala E; Tuomaala S; Eskelin S; Kivelä T
    Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
    Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
    Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
    Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
    Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival melanoma in the Netherlands: a nationwide study.
    Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational risks for uveal melanoma results from a case-control study in nine European countries.
    Lutz JM; Cree I; Sabroe S; Kvist TK; Clausen LB; Afonso N; Ahrens W; Ballard TJ; Bell J; Cyr D; Eriksson M; Févotte J; Guénel P; Hardell L; Jöckel KH; Miranda A; Merletti F; Morales-Suarez-Varela MM; Stengrevics A; Lynge E
    Cancer Causes Control; 2005 May; 16(4):437-47. PubMed ID: 15953986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.